Clinical trials: Quality of Life in Schizophrenia
Schizophrenia and Schizoaffective Disorder
Effects of RAS in SZ
The two main groups of medicated patients with schizophrenia (SZ) are those receiving second-generation antipsychotics and those receiving first-generation antipsychotics.
- Trial name
- NCT07086040
- Testing
- RAS incorporated in upper-limb movement training, Upper-limb movement training
- Where
- Taiwan
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Shu-Mei Wang
Schizophrenia Patients
Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients.
The goal of this clinical trial is to learn if video game-facilitated group activity helps to improve the quality of life and social function in inpatients with chronic schizophrenia.
- Trial name
- NCT07148609
- Testing
- Video game-facilitated group activity
- Where
- Taiwan
- Volunteers
- 64 people
- Sponsor
- TsaoTun Psychiatric Center, Department of Health, Taiwan
Chronic Schizophrenia, Quality of Life
Resourcefulness Group Intervention on Recovery and Quality of Life
The purpose of this study was to test the effects of resourcefulness group intervention on facilitating recovery and improving the quality of life in patients with chronic schizophrenia.
- Conditions
- Chronic Schizophrenia, Quality of Life, Recovery
- Trial name
- NCT06206798
- Testing
- Resourcefulness Group
- Where
- Taiwan
- Volunteers
- 40 people
- Sponsor
- National Taipei University of Nursing and Health Sciences
Schizophrenia
Cognition, Functioning and Quality of Life
People affected by schizophrenia often experience poor concentration, lapses in memory and difficulty with completing tasks; and this set of problems are known as neuro-cognitive deficits.
- Trial name
- NCT00182442
- Testing
- Olanzapine & Quetiapine
- Where
- Canada
- Volunteers
- 80 people
- Sponsor
- Hamilton Health Sciences Corporation
Schizophrenia, Balance; Distorted
Comparison of the Effects of Physical Activity and Virtual Reality Training in Patients With Schizophrenia
The current study aims to compare the effects of physical activity and Virtual Reality training on physical function, cognition and quality of life in patients with Schizophrenia.
- Conditions
- Schizophrenia, Balance; Distorted, Cognitive Impairment
- Trial name
- NCT07173465
- Testing
- Virtual Reality (VR), Physical Activity (PA group), occupational therapy
- Where
- Turkey (Türkiye)
- Volunteers
- 45 people
- Sponsor
- Yeditepe University
Schizophrenics
Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment
Schizophrenia is a chronic and severe psychiatric disorder, these patients suffer from positive symptoms, negative symptoms and cognitive deficits, of which working memory problems are considered a central cognitive impairment.
- Trial name
- NCT04754750
- Testing
- Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA]
- Volunteers
- 72 people
- Sponsor
- Calo Psychiatric Center
Inflammatory Bowel Diseases, Depressive Episode
Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health
This study is a large population-based analysis in the United Kingdom (UK) using routine primary care data to investigate the impacts on quality-of-life outcomes and use of healthcare services in people aged 5 - 25 years…
- Conditions
- Inflammatory Bowel Diseases, Depressive Episode, Recurrent Depressive Disorder, Anxiety Disorder
- Trial name
- NCT05206734
- Testing
- No specific intervention
- Where
- United Kingdom
- Volunteers
- 19,469 people, healthy volunteers welcome
- Sponsor
- Momentum Data
Schizophrenia
Lurasidone Non-Interventional Study in Schizophrenia Patients
The study is a multicentric, national, non-interventional, prospective, single arm study. The main goal of this study is to gather information about the effects, in a real-life setting, of lurasidone treatment on patient's…
- Trial name
- NCT06527885
- Testing
- Lurasidone
- Where
- 3 sites in Italy
- Volunteers
- 61 people
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
Schizophrenia
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics
To evaluate the QOL (subjective effectiveness) in patients with schizophrenia, treated with atypical antipsychotics.
- Trial name
- Xperience (NCT00689325)
- Where
- 37 sites in Netherlands
- Volunteers
- 158 people
- Sponsor
- AstraZeneca